To be really frank, I don't know that we understand who those 12% are. I don't think we understand why they are not filling their prescriptions. Is there a certain class of drugs that is the problem? Is there a certain regional distribution that is the problem? We don't know enough for me to say that I can help you design a target solution.
In a normal environment, when 95% or 96% of people are getting everything they want and you have a gap that's 4% or 5%, you do try to find solutions to address the gap. You don't suggest we throw everything out and start from scratch.
In the short term, that's the way we would propose, the way it would logically make sense to move forward.